Aspirin

Product NDC
55301-227
11-digit product format
553010227
Labeler code
55301
Product ID
55301-227_36bfc6eb-7d1d-473d-a7c1-a0cf98ab6141
Type
HUMAN OTC DRUG
Nonproprietary name
Aspirin
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Labeler
ARMY AND AIR FORCE EXCHANGE SERVICE
Application
part343
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
1992-12-14
Marketing end
0000-00-00
Substance
ASPIRIN
Active strength
325 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct55301-227DDiscontinued by firm2026-10-15
excluded packagepackage55301-22755301-227-12DDiscontinued by firm2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 22 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage55301-227-12d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage55301-227-12f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage55301-227-122ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage55301-227-12a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage55301-227-12cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage55301-227-12cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage55301-227-12302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage55301-227-12ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage55301-227-120efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage55301-227-12ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage55301-227-12367a005e9d99…383a685ebd0f…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ASPIRINACTIVE INGREDIENTR16CO5Y76EASPIRIN REGULAR STRENGTH (ASPIRIN) TABLET, COATED [ARMY AND AIR FORCE EXCHANGE SERVICE]2
ASPIRINACTIVE MOIETYR16CO5Y76EASPIRIN REGULAR STRENGTH (ASPIRIN) TABLET, COATED [ARMY AND AIR FORCE EXCHANGE SERVICE]2
D&C YELLOW NO. 10INACTIVE INGREDIENT35SW5USQ3GASPIRIN REGULAR STRENGTH (ASPIRIN) TABLET, COATED [ARMY AND AIR FORCE EXCHANGE SERVICE]2
FD&C YELLOW NO. 6INACTIVE INGREDIENTH77VEI93A8ASPIRIN REGULAR STRENGTH (ASPIRIN) TABLET, COATED [ARMY AND AIR FORCE EXCHANGE SERVICE]2
FERROSOFERRIC OXIDEINACTIVE INGREDIENTXM0M87F357ASPIRIN REGULAR STRENGTH (ASPIRIN) TABLET, COATED [ARMY AND AIR FORCE EXCHANGE SERVICE]2
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOASPIRIN REGULAR STRENGTH (ASPIRIN) TABLET, COATED [ARMY AND AIR FORCE EXCHANGE SERVICE]2
POLYDEXTROSEINACTIVE INGREDIENTVH2XOU12IEASPIRIN REGULAR STRENGTH (ASPIRIN) TABLET, COATED [ARMY AND AIR FORCE EXCHANGE SERVICE]2
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1AASPIRIN REGULAR STRENGTH (ASPIRIN) TABLET, COATED [ARMY AND AIR FORCE EXCHANGE SERVICE]2
Polyvinyl Acetate PhthalateINACTIVE INGREDIENT58QVG85GW3ASPIRIN REGULAR STRENGTH (ASPIRIN) TABLET, COATED [ARMY AND AIR FORCE EXCHANGE SERVICE]2
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3ASPIRIN REGULAR STRENGTH (ASPIRIN) TABLET, COATED [ARMY AND AIR FORCE EXCHANGE SERVICE]2
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4ASPIRIN REGULAR STRENGTH (ASPIRIN) TABLET, COATED [ARMY AND AIR FORCE EXCHANGE SERVICE]2
SODIUM ALGINATEINACTIVE INGREDIENTC269C4G2ZQASPIRIN REGULAR STRENGTH (ASPIRIN) TABLET, COATED [ARMY AND AIR FORCE EXCHANGE SERVICE]2
SODIUM BICARBONATEINACTIVE INGREDIENT8MDF5V39QOASPIRIN REGULAR STRENGTH (ASPIRIN) TABLET, COATED [ARMY AND AIR FORCE EXCHANGE SERVICE]2
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APASPIRIN REGULAR STRENGTH (ASPIRIN) TABLET, COATED [ARMY AND AIR FORCE EXCHANGE SERVICE]2
TALCINACTIVE INGREDIENT7SEV7J4R1UASPIRIN REGULAR STRENGTH (ASPIRIN) TABLET, COATED [ARMY AND AIR FORCE EXCHANGE SERVICE]2
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPASPIRIN REGULAR STRENGTH (ASPIRIN) TABLET, COATED [ARMY AND AIR FORCE EXCHANGE SERVICE]2
TRIACETININACTIVE INGREDIENTXHX3C3X673ASPIRIN REGULAR STRENGTH (ASPIRIN) TABLET, COATED [ARMY AND AIR FORCE EXCHANGE SERVICE]2
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMASPIRIN REGULAR STRENGTH (ASPIRIN) TABLET, COATED [ARMY AND AIR FORCE EXCHANGE SERVICE]2

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
55301-227-12553010227121 BOTTLE, PLASTIC in 1 CARTON (55301-227-12) > 100 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC1992-12-140000-00-00NoNoCurrent